Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT01324180 · COMPLETED
Trial details
- NCT number
- NCT01324180
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-18
- Primary completion
- 2016-11-16
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.